Français Japonais Chinois Allemand Néerlandais Espagnol Portugais

    News

    Roquette to make second investment in Vic-sur-Aisne plant

    Roquette—a world leader in nutrition from innovative plant-based ingredients—is set to strengthen its presence in Hauts-de-France by investing €40 million in pea proteins in Aisne.

    Rigby Group chooses Hauts-de-France

    Rigby Group subsidiary Altimance, an IT services specialist, will soon begin operations in Valenciennes, joining La Serre Numérique, La Nouvelle Forge and La Cité des Congrès in the Rives Créatives de l’Escaut...

    All news

    New biopharma start-up at Lille's Institut Pasteur

    10 Aug 2016 | Health Nutrition, A region on the move

    A revolutionary start-up has just seen the light of day at the Institut Pasteur campus in Lille. Immune InsighT is a biotech business specialized in analyses to confirm new drug candidates are safe. The company harnesses rare expertise to offer a unique services to clients around the world.

    Immune InsighT at Lille's Institut Pasteur

    Lille's Institut Pasteur is an international pace-setter and a key player in medical research. Over the past fifteen years, a dozen start-ups have been set up on its campus or through its research teams—including Immune InsighT in 2016.

    Immune InsighT offers an all-new, high-end method for confirming the safety of new drug candidates designed to treat cancer, transplants, auto-immune system and inflammatory illnesses, and applications in agrifood and the cosmetic industry prior to the launch of clinical tests. This fast-moving young company offers unique services worldwide.

    Completing the full range of tests offered by Immune InsighT early on enables client companies to identify the undesirable effects of drug candidates or other molecules on the immune system both reliably and quickly—and to anticipate the potential failure of a long and costly clinical trial well in advance. 

     

    Source: Lille's Institut Pasteur

    Back to news